Literature DB >> 31006841

Curcumin induces apoptotic cell death and protective autophagy by inhibiting AKT/mTOR/p70S6K pathway in human ovarian cancer cells.

Li-Dong Liu1,2, Ying-Xin Pang1,2, Xin-Rui Zhao1,2, Rui Li1,2, Cheng-Juan Jin1,2, Jing Xue1,2, Rui-Ying Dong3,4, Pei-Shu Liu5,6.   

Abstract

PURPOSE: Curcumin (Cur), a yellow-colored dietary flavor from the plant (Curcuma longa), has been demonstrated to potentially resist diverse diseases, including ovarian cancer, but drug resistance becomes a major limitation of its success clinically. The key molecule or mechanism associated with curcumin resistance in ovarian cancer still remains unclear. The aim of our study was to investigate the effects of curcumin on autophagy in ovarian cancer cells and elucidate the underlying mechanism.
METHODS: In our study, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), EdU proliferation assay and colony-forming assay were used to assess cell viability. Apoptosis was detected by western blot and flow cytometric analysis of apoptosis. Autophagy was defined by both electron microscopy and immunofluorescence staining markers such as microtubule-associated protein 1 light chain 3 (LC3). Plasmid construction and shRNA transfection helped us to confirm the function of curcumin.
RESULTS: Curcumin reduced cell viability and induced apoptotic cell death by MTT assay in human ovarian cancer cell lines SK-OV-3 and A2780 significantly. Electron microscopy, western blot and immunofluorescence staining proved that curcumin could induce protective autophagy. Moreover, treatment with autophagy-specific inhibitors or stable knockdown of LC3B by shRNA could markedly enhance curcumin-induced apoptosis. Finally, the cells transiently transfected with AKT1 overexpression plasmid demonstrated that autophagy had a direct relationship with the AKT/mTOR/p70S6K pathway.
CONCLUSIONS: Curcumin can induce protective autophagy of human ovarian cancer cells by inhibiting the AKT/mTOR/p70S6K pathway, indicating the synergistic effects of curcumin and autophagy inhibition as a possible strategy to overcome the limits of current therapies in the eradication of epithelial ovarian cancer.

Entities:  

Keywords:  AKT/mTOR/p70S6K; Apoptotic cell death; Autophagy; Curcumin; Ovarian cancer

Mesh:

Substances:

Year:  2019        PMID: 31006841     DOI: 10.1007/s00404-019-05058-3

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  16 in total

1.  Preparation and evaluation of the anti-cancer properties of RGD-modified curcumin-loaded chitosan/perfluorohexane nanocapsules in vitro.

Authors:  Liang Wang; Shixia Zhu; Chunpeng Zou; Hongju Kou; Maosheng Xu; Jie Li
Journal:  Heliyon       Date:  2022-07-11

Review 2.  Polyphenol-Mediated Autophagy in Cancer: Evidence of In Vitro and In Vivo Studies.

Authors:  Monica Benvenuto; Loredana Albonici; Chiara Focaccetti; Sara Ciuffa; Sara Fazi; Loredana Cifaldi; Martino Tony Miele; Fernando De Maio; Ilaria Tresoldi; Vittorio Manzari; Andrea Modesti; Laura Masuelli; Roberto Bei
Journal:  Int J Mol Sci       Date:  2020-09-10       Impact factor: 5.923

3.  A Network Pharmacology Approach to Explore the Mechanisms of Shugan Jianpi Formula in Liver Fibrosis.

Authors:  Chang Fan; Fu Rong Wu; Jia Fu Zhang; Hui Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-12       Impact factor: 2.629

4.  Curcumin at Low Doses Potentiates and at High Doses Inhibits ABT-737-Induced Platelet Apoptosis.

Authors:  Natalia Rukoyatkina; Valentina Shpakova; Julia Sudnitsyna; Michael Panteleev; Stephanie Makhoul; Stepan Gambaryan; Kerstin Jurk
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

Review 5.  Antitumor effects and molecular mechanisms of action of natural products in ovarian cancer.

Authors:  Yun-Bo Yan; Qing Tian; Ji-Fang Zhang; Ying Xiang
Journal:  Oncol Lett       Date:  2020-08-20       Impact factor: 2.967

Review 6.  Therapeutic role of curcumin and its novel formulations in gynecological cancers.

Authors:  Mohammad Hossein Pourhanifeh; Maryam Darvish; Javad Tabatabaeian; Mahboobeh Rabbani Fard; Reza Mottaghi; Mohammad Javad Azadchehr; Moghaddaseh Jahanshahi; Amirhossein Sahebkar; Hamed Mirzaei
Journal:  J Ovarian Res       Date:  2020-11-04       Impact factor: 4.234

7.  The inhibitory effect of curcumin via fascin suppression through JAK/STAT3 pathway on metastasis and recurrence of ovary cancer cells.

Authors:  Mi Ju Kim; Ki-Su Park; Kyoung-Tae Kim; Eun Young Gil
Journal:  BMC Womens Health       Date:  2020-11-19       Impact factor: 2.809

8.  Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.

Authors:  Lidong Liu; Zhiwei Zhang; Guoxiang Zhang; Ting Wang; Yingchun Ma; Wei Guo
Journal:  J Transl Med       Date:  2020-09-20       Impact factor: 5.531

Review 9.  The Therapeutic Potential of Common Herbal and Nano-Based Herbal Formulations against Ovarian Cancer: New Insight into the Current Evidence.

Authors:  Fatemeh Rezaei-Tazangi; Hossein Roghani-Shahraki; Mahdi Khorsand Ghaffari; Firoozeh Abolhasani Zadeh; Aynaz Boostan; Reza ArefNezhad; Hossein Motedayyen
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-17

Review 10.  Curcumin and colorectal cancer: An update and current perspective on this natural medicine.

Authors:  Wenhao Weng; Ajay Goel
Journal:  Semin Cancer Biol       Date:  2020-02-20       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.